Vince Jensen was named chief clinical operating officer of City of Hope. Jensen will lead clinical operations on City of Hope’s main campus in Los Angeles and throughout its network of more than 35 care locations in Southern California.
Over the past three decades, cancer genetics has transformed precision oncology. Germline testing has advanced from single-gene Sanger sequencing to parallel sequencing of hundreds of genes, while tumor (somatic) testing has expanded with the rise of targeted therapies based on point mutations, copy number changes and other alterations.
